gray market glp 1 GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Receptor Agonist Market Growth

GLP-1 agonists and infertility: Mechanistic insights and clinical evidence

Additionally, in July 2023, Sandoz expanded its portfolio with the launch of a new biosimilar GLP-1 medication, enhancing market access

Pharmacy workflow integration GLP-1 therapy stands or falls on how quickly the drug moves from prescriber to pharmacy to patient

They are also being explored for off-label uses such as CKD, MASLD, substance use disorders, chronic pain, neurodegenerative disorders, and PCOS

C., Allen, S., Sarker, E., Wu, Q., Stefanski, A., Jouravskaya, I., & ATTAIN-2 Trial Investigators (2026)

What GLP-1 receptor agonists do, in plain terms, is supply pharmacologically the satiety signal the body was not producing effectively enough on its own